Sign in

CIK 0000926617

  • Non-accelerated filer
  • Smaller reporting company

Aspira Women's Health Inc.

Sign in to watch
Ticker
AWHL
Exchange
OTC
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330595156
Phone
+1 512-519-0400
Business address
12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
Former names
VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market buy Director bought 30,932 shares at an average $1.70 ($52,530)
  6. 4 Open-market buy VP, Sales and Marketing bought 3,000 shares at an average $1.75 ($5,248)
  7. 4 Open-market buy Chief Accounting Officer bought 19,525 shares at an average $1.18 ($23,044)
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market buy VP Sales and Marketing bought 957 shares at $1.98 ($1,895)
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market buy VP Sales and Marketing bought 767 shares at $2.81 ($2,155)
  13. 4 Grant or award Director acquired 9,495 shares (grant or award)
  14. 4 Open-market buy VP of Corporate Strategy bought 2,000 shares at an average $3.01 ($6,016)
  15. 4 Open-market buy VP Sales and Marketing bought 717 shares at $2.81 ($2,015)
  16. 4 Open-market buy VP Sales and Marketing bought 1,000 shares at $2.75 ($2,750)
  17. 4 Open-market buy VP Sales and Marketing bought 500 shares at $4.16 ($2,080)
  18. 4 Open-market buy VP Sales and Marketing bought 489 shares at $4.04 ($1,976)
  19. 4 Open-market buy S.V.P & C.S.O bought 1,000 shares at $4.72 ($4,720)
  20. 4 Open-market sale Director sold 4,000 shares at $4.98 ($19,920)

Page 20 of 28 · 551 filings